Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$91,570
-$530,381 QoQ
Shares Held
42,591
-89.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,145,056 across 362 Biotechnology names. ALEC ranks #246 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in ALEC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,570 | 42,591 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $621,951 | 398,687 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,585,189 | 873,375 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $237,713 | 169,795 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $153,855 | 125,086 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $333,715 | 176,569 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $823,888 | 176,800 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $345,353 | 76,069 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $615,394 | 102,225 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $1,541,959 | 193,228 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $899,592 | 138,826 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $672,939 | 111,970 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $787,956 | 127,295 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,280,579 | 138,741 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $1,481,511 | 156,608 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $196,087 | 19,300 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $264,522 | 18,563 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,269,868 | 109,921 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,674,873 | 73,395 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,191,745 | 57,213 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,016,415 | 100,120 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $493,237 | 32,600 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $416,817 | 39,565 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,634,693 | 66,886 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,087,345 | 45,062 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||